~ Buy the VOQUEZNA DUAL PAK (amoxicillin; vonoprazan fumarate) Drug Profile, 2024 PDF Report in the Report Store ~

VOQUEZNA DUAL PAK Drug Patent Profile

✉ Email this page to a colleague

When do Voquezna Dual Pak patents expire, and what generic alternatives are available?

Voquezna Dual Pak is a drug marketed by Phathom and is included in one NDA. There are two patents protecting this drug.

This drug has one hundred and three patent family members in forty-three countries.

The generic ingredient in VOQUEZNA DUAL PAK is amoxicillin; vonoprazan fumarate. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; vonoprazan fumarate profile page.

DrugPatentWatch^® Generic Entry Outlook for Voquezna Dual Pak

Voquezna Dual Pak will be eligible for patent challenges on May 3, 2026. This date may extended up to six months if a pediatric exclusivity extension is applied to the drug's patents.

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be May 3, 2032. This may change due to patent challenges or generic licensing.

Indicators of Generic Entry

< Available with Subscription >

Try a Trial

Summary for VOQUEZNA DUAL PAK

International Patents:	103
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for VOQUEZNA DUAL PAK
What excipients (inactive ingredients) are in VOQUEZNA DUAL PAK?	VOQUEZNA DUAL PAK excipients list
DailyMed Link:	VOQUEZNA DUAL PAK at DailyMed

Drug patent expirations by year for VOQUEZNA DUAL PAK

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for VOQUEZNA DUAL PAK

Generic Entry Date for VOQUEZNA DUAL PAK^: ⤷ Try a Trial* Constraining patent/regulatory exclusivity: GENERATING ANTIBIOTIC INCENTIVES NOW NDA: 215153 Dosage: CAPSULE, TABLET;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Anatomical Therapeutic Chemical (ATC) Classes for VOQUEZNA DUAL PAK

A02BC	Proton pump inhibitors
A02B	DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02	DRUGS FOR ACID RELATED DISORDERS
A	Alimentary tract and metabolism

J01CA	Penicillins with extended spectrum
J01C	BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for VOQUEZNA DUAL PAK

VOQUEZNA DUAL PAK is protected by two US patents and two FDA Regulatory Exclusivities.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of VOQUEZNA DUAL PAK is ⤷ Try a Trial.

This potential generic entry date is based on GENERATING ANTIBIOTIC INCENTIVES NOW.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting VOQUEZNA DUAL PAK

1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Pharmaceutical composition
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

FDA Regulatory Exclusivity protecting VOQUEZNA DUAL PAK

NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷ Try a Trial

GENERATING ANTIBIOTIC INCENTIVES NOW
Exclusivity Expiration: ⤷ Try a Trial

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Phathom	VOQUEZNA DUAL PAK	amoxicillin; vonoprazan fumarate	CAPSULE, TABLET;ORAL	215153-001	May 3, 2022		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Phathom	VOQUEZNA DUAL PAK	amoxicillin; vonoprazan fumarate	CAPSULE, TABLET;ORAL	215153-001	May 3, 2022		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Phathom	VOQUEZNA DUAL PAK	amoxicillin; vonoprazan fumarate	CAPSULE, TABLET;ORAL	215153-001	May 3, 2022		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial		Y		⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for VOQUEZNA DUAL PAK

When does loss-of-exclusivity occur for VOQUEZNA DUAL PAK?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 2842
Estimated Expiration: ⤷ Try a Trial

Australia

Patent: 09277443
Estimated Expiration: ⤷ Try a Trial

Brazil

Patent: 0916689
Estimated Expiration: ⤷ Try a Trial

Canada

Patent: 32243
Estimated Expiration: ⤷ Try a Trial

Patent: 36400
Estimated Expiration: ⤷ Try a Trial

Chile

Patent: 11000170
Estimated Expiration: ⤷ Try a Trial

Patent: 13000224
Estimated Expiration: ⤷ Try a Trial

China

Patent: 2164581
Estimated Expiration: ⤷ Try a Trial

Patent: 2743330
Estimated Expiration: ⤷ Try a Trial

Patent: 4784180
Estimated Expiration: ⤷ Try a Trial

Colombia

Patent: 90638
Estimated Expiration: ⤷ Try a Trial

Costa Rica

Patent: 110110
Estimated Expiration: ⤷ Try a Trial

Dominican Republic

Patent: 011000033
Estimated Expiration: ⤷ Try a Trial

Patent: 013000172
Estimated Expiration: ⤷ Try a Trial

Ecuador

Patent: 11010855
Estimated Expiration: ⤷ Try a Trial

Eurasian Patent Organization

Patent: 1170272
Estimated Expiration: ⤷ Try a Trial

Patent: 1201451
Estimated Expiration: ⤷ Try a Trial

European Patent Office

Patent: 09985
Estimated Expiration: ⤷ Try a Trial

Patent: 64833
Estimated Expiration: ⤷ Try a Trial

Georgia, Republic of

Patent: 0146122
Estimated Expiration: ⤷ Try a Trial

Patent: 0146166
Estimated Expiration: ⤷ Try a Trial

Japan

Patent: 95356
Estimated Expiration: ⤷ Try a Trial

Patent: 93363
Estimated Expiration: ⤷ Try a Trial

Patent: 11529445
Estimated Expiration: ⤷ Try a Trial

Patent: 13047239
Estimated Expiration: ⤷ Try a Trial

Malaysia

Patent: 6305
Estimated Expiration: ⤷ Try a Trial

Patent: 9461
Estimated Expiration: ⤷ Try a Trial

Mexico

Patent: 11000757
Estimated Expiration: ⤷ Try a Trial

Morocco

Patent: 556
Estimated Expiration: ⤷ Try a Trial

New Zealand

Patent: 1344
Estimated Expiration: ⤷ Try a Trial

Patent: 2592
Estimated Expiration: ⤷ Try a Trial

Peru

Patent: 110591
Estimated Expiration: ⤷ Try a Trial

Patent: 140977
Estimated Expiration: ⤷ Try a Trial

Patent: 141585
Estimated Expiration: ⤷ Try a Trial

Singapore

Patent: 6685
Estimated Expiration: ⤷ Try a Trial

South Africa

Patent: 1101198
Estimated Expiration: ⤷ Try a Trial

South Korea

Patent: 110042334
Estimated Expiration: ⤷ Try a Trial

Spain

Patent: 60962
Estimated Expiration: ⤷ Try a Trial

Patent: 69592
Estimated Expiration: ⤷ Try a Trial

Taiwan

Patent: 1010992
Estimated Expiration: ⤷ Try a Trial

Patent: 1431552
Estimated Expiration: ⤷ Try a Trial

Tunisia

Patent: 11000030
Estimated Expiration: ⤷ Try a Trial

Ukraine

Patent: 3332
Estimated Expiration: ⤷ Try a Trial

Uruguay

Patent: 008
Estimated Expiration: ⤷ Try a Trial

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering VOQUEZNA DUAL PAK around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Russian Federation	2008112153	1-ГЕТЕРОЦИКЛИЛСУЛЬФОНИЛ, 2-АМИНОМЕТИЛ, 5-(ГЕТЕРО)АРИЛ ЗАМЕЩЕННЫЕ 1-Н-ПИРРОЛ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ СЕКРЕЦИИ КИСЛОТЫ	⤷ Try a Trial
Slovenia	2327692		⤷ Try a Trial
Morocco	29773	DERIVES DE 1-H-PYRROLE SUBSTITUES PAR UN GROUPE 1-HETEROCYCLYSULFONYLE, 2-AMINOMETHYLE, 5-(HETERO) ARYLE EN TANT QU'INHIBITEURS DES SECRETIONS ACIDES	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration